Media coverage about Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) has trended somewhat positive this week, according to Alpha One Sentiment. The research group, a unit of Accern, identifies positive and negative media coverage by reviewing more than 20 million news and blog sources. Alpha One ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Tonix Pharmaceuticals Holding Corp. earned a news impact score of 0.12 on Alpha One’s scale. Alpha One also gave news headlines about the company an impact score of 94 out of 100, indicating that recent media coverage is extremely likely to have an effect on the company’s share price in the immediate future.

These are some of the news headlines that may have effected Alpha One Sentiment’s scoring:

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) traded down 2.73% on Friday, hitting $4.27. The stock had a trading volume of 145,839 shares. Tonix Pharmaceuticals Holding Corp. has a 1-year low of $3.30 and a 1-year high of $37.70. The firm’s market capitalization is $31.97 million. The stock’s 50-day moving average is $3.08 and its 200 day moving average is $1.17.

TRADEMARK VIOLATION NOTICE: This story was originally reported by Financial Market News and is the property of of Financial Market News. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this story can be accessed at

5 Day Chart for NASDAQ:TNXP

Receive News & Ratings for Tonix Pharmaceuticals Holding Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tonix Pharmaceuticals Holding Corp. and related companies with's FREE daily email newsletter.